<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-22605</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Renal transplantation in patients with an augmentation cystoplasty</dc:title>
<dc:description xml:lang="en">OBJECTIVES: To asses the impact of augmentation enterocystoplasty on the success of cadaveric renal transplantation in patients with dysfunctional bladders. PATIENTS AND METHODS: Between 1980 and 2001, 3 men and a woman with severe dysfunctional lower urinary tract underwent a total of 4 cadaveric renal transplantations. The etiologies of the bladder dysfunction were bladder contraction secondary to urinary tuberculosis in all cases. In 3 patients were performed an enterocystoplasty with ileocecal segment and one with ileon. RESULTS: The overall allograft survival was 58.7 months. Two patients have functioning grafts 27 and 74 months after transplant, 1 has died due to an intestinal disease and other had crohnic rejection after follow-up of 98 months. Technical complications occurred in 3 patients. All patients remain continent without catheterization after the transplantation. CONCLUSIONS: Enterocystoplasty is a safe and effective method of restoring lower urinary tract function in the patient with end stage renal disease and a small non compliant bladder (AU)</dc:description>
<dc:publisher>Ene Ediciones, S.A.</dc:publisher>
<dc:description xml:lang="es">OBJETIVOS: Evaluar la evolución y resultados del trasplante renal de donante cadáver en pacientes con ampliaciones vesicales realizadas por alteración del tracto urinario inferior (TUI). PACIENTES Y MÉTODOS: Entre 1980 y 2001 hemos realizado 4 trasplantes renales en pacientes con fibrosis vesical restrictiva secundaria a tuberculosis (3 hombres y 1 mujer). Previamente se realizó ampliación vesical intestinal: 3 ileocecocistoplastias y 1 ileocistoplastia. RESULTADOS: Tras 27 y 74 meses desde el trasplante renal 2 pacientes conservan buena función renal. Un paciente perdió el injerto por rechazo crónico a los 98 meses y el restante falleció a los 36 meses por sepsis de origen intestinal, conservando el injerto funcionante. Tres casos tuvieron complicaciones post-quirúrgicas que precisaron de tratamiento instrumental. Ningún paciente presentó incontinencia urinaria. CONCLUSIONES: La enterocistoplastia es un procedimiento seguro y eficaz para pacientes con alteración del TUI y que precisan de trasplante renal (AU)</dc:description>
<dc:source>Actas Urol Esp;27(4): 281-285, abr. 2003.</dc:source>
<dc:title xml:lang="es">Trasplante renal en pacientes con enterocistoplastia</dc:title>
<dc:type>article</dc:type>
<dc:creator>Jiménez Cruz, F. J</dc:creator>
<dc:creator>Alapont Alacreu, J. M</dc:creator>
<dc:creator>Pontones Moreno, J. L</dc:creator>
<dc:creator>Alonso Gorrea, M</dc:creator>
<dc:creator>Sánchez Plumed, J</dc:creator>
<dc:creator>Pacheco Bru, J. J</dc:creator>
<dc:language>es</dc:language>
<dc:identifier>ibc-22605</dc:identifier>
<dc:subject>^d7265</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d11622</dc:subject>
<dc:subject>^d6236</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d14947</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d2468</dc:subject>
<dc:subject>^d29475</dc:subject>
<dc:subject>^d14949</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d14575</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d50497</dc:subject>
<dc:date>200304</dc:date>
</metadata>
</record>
</ibecs-document>
